Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: Effect of contrast agent size

Medical Physics

Volumn 37, Issue 11, 2010, Pages 5746-5755

  Jaspers, Karolien ^a,b   Leiner, Tim ^a,b   Dijkstra, Petra ^c   Oostendorp, Marlies ^a,b   Van Golde, Jolanda M ^b   Post, Mark J ^a,c   Backes, Walter H ^a,b,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

contrast agent size; DCE MRI; muscle microvascular; pharmacokinetic modeling

Indexed keywords

BLOOD VESSELS; MAGNETIC RESONANCE IMAGING; PARAMETER ESTIMATION; PHARMACOKINETICS; POLYPROPYLENES; SOFTWARE AGENTS; UNCERTAINTY ANALYSIS;

ACQUISITION PROTOCOLS; CONTRAST AGENT; DCE-MRI; DYNAMIC CONTRAST ENHANCED MRIS (DCE); ESTIMATION UNCERTAINTIES; MICROVASCULAR; PHARMACOKINETIC MODEL; PHARMACOKINETIC PROPERTIES;

MUSCLE;

ORYCTOLAGUS CUNICULUS;

EID: 78149450609     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3484057     Document Type: Article

References (53)

1. S. Attanasio and J. Snell, " Therapeutic angiogenesis in the management of critical limb ischemia: Current concepts and review.," Cardiol. Rev. 17 (3), 115-120 (2009). 10.1097/CRD.0b013e318199e9b7 1061-5377
2. W. S. Jones and B. H. Annex, " Growth factors for therapeutic angiogenesis in peripheral arterial disease.," Curr. Opin. Cardiol. ZZZZZZ 0268-4705 22 (5), 458-463 (2007). 10.1097/HCO.0b013e328236741b (Pubitemid 47356953)
3. S. H. Schirmer, F. C. van Nooijen, J. J. Piek, and N. van Royen, " Stimulation of collateral artery growth: Travelling further down the road to clinical application.," Heart ZZZZZZ 1355-6037 95 (3), 191-197 (2009). 10.1136/hrt.2007.136119
4. M. Simons, " Angiogenesis: Where do we stand now?," Circulation CIRCAZ 0009-7322 111 (12), 1556-1566 (2005). 10.1161/01.CIR.0000159345.00591.8F (Pubitemid 40470653)
5. Q. G. de Lussanet, " Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 63 (5), 1309-1315 (2005). 10.1016/j.ijrobp.2005.04.052
6. M. Oostendorp, M. J. Post, and W. H. Backes, " Vessel growth and function: Depiction with contrast-enhanced MR imaging.," Radiology RADLAX 0033-8419 251 (2), 317-335 (2009). 10.1148/radiol.2512080485
7. A. R. Padhani, " Dynamic contrast-enhanced MRI in clinical oncology: Current status and future directions.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 16 (4), 407-422 (2002). 10.1002/jmri.10176 (Pubitemid 35167876)
8. M. A. Zahra, K. G. Hollingsworth, E. Sala, D. J. Lomas, and L. T. Tan, " Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy.," Lancet Oncol. LOANBN 1470-2045 8 (1), 63-74 (2007). 10.1016/S1470-2045(06)71012-9 (Pubitemid 44943092)
9. N. Al-Saadi, " Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance.," Circulation CIRCAZ 0009-7322 101 (12), 1379-1383 (2000).
10. N. Wilke, " Myocardial perfusion reserve: Assessment with multisection, quantitative, first-pass MR imaging.," Radiology RADLAX 0033-8419 204 (2), 373-384 (1997).
11. Q. G. de Lussanet, " Dynamic contrast-enhanced MRI of muscle perfusion combined with MR angiography of collateral artery growth in a femoral artery ligation model.," NMR Biomed. NMRBEF 0952-3480 20, 717-725 (2007). 10.1002/nbm.1133 (Pubitemid 350285268)
12. A. Z. Faranesh, D. L. Kraitchman, and E. R. McVeigh, " Measurement of kinetic parameters in skeletal muscle by magnetic resonance imaging with an intravascular agent.," Magn. Reson. Med. MRMEEN 0740-3194 55 (5), 1114-1123 (2006). 10.1002/mrm.20884
13. S. M. Galbraith, " Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: Comparison of quantitative and semi-quantitative analysis.," NMR Biomed. NMRBEF 0952-3480 15 (2), 132-142 (2002). 10.1002/nbm.731 (Pubitemid 34213403)
14. R. B. Thompson, " Measurement of skeletal muscle perfusion during postischemic reactive hyperemia using contrast-enhanced MRI with a step-input function.," Magn. Reson. Med. MRMEEN 0740-3194 54 (2), 289-298 (2005). 10.1002/mrm.20535 (Pubitemid 41033545)
15. T. A. Goldstein, M. Jerosch-Herold, B. Misselwitz, H. Zhang, R. J. Gropler, and J. Zheng, " Fast mapping of myocardial blood flow with MR first-pass perfusion imaging.," Magn. Reson. Med. MRMEEN 0740-3194 59 (6), 1394-1400 (2008). 10.1002/mrm.21559 (Pubitemid 351813270)
16. Y. Luo, " Evaluation of tissue perfusion in a rat model of hind-limb muscle ischemia using dynamic contrast-enhanced magnetic resonance imaging.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 16 (3), 277-283 (2002). 10.1002/jmri.10169 (Pubitemid 34920426)
17. H. J. Aerts, N. A. van Riel, and W. H. Backes, " System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: Influence of contrast injection.," Magn. Reson. Med. MRMEEN 0740-3194 59 (5), 1111-1119 (2008). 10.1002/mrm.21575 (Pubitemid 351590525)
18. E. Henderson, B. K. Rutt, and T. Y. Lee, " Temporal sampling requirements for the tracer kinetics modeling of breast disease.," Magn. Reson. Imaging MRIMDQ 0730-725X 16 (9), 1057-1073 (1998). 10.1016/S0730-725X(98) 00130-1 (Pubitemid 29196842)
19. R. G. Lopata, W. H. Backes, P. P. van den Bosch, and N. A. van Riel, " On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging.," Magn. Reson. Med. MRMEEN 0740-3194 58 (2), 425-429 (2007). 10.1002/mrm.21336 (Pubitemid 47267663)
20. B. Misselwitz, H. Schmitt-Willich, W. Ebert, T. Frenzel, and H. J. Weinmann, " Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent.," MAGMA (N.Y.) MAGMEY 0968-5243 12 (2-3), 128-134 (2001). 10.1007/BF02668094
21. K. Jaspers, " Reliability of pharmacokinetic parameters: Small vs. medium-sized contrast agents.," Magn. Reson. Med. MRMEEN 0740-3194 62 (3), 779-787 (2009). 10.1002/mrm.22035
22. S. Walker-Samuel, M. O. Leach, and D. J. Collins, " Evaluation of response to treatment using DCE-MRI: The relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis.," Phys. Med. Biol. PHMBA7 0031-9155 51 (14), 3593-3602 (2006). 10.1088/0031-9155/51/14/021 (Pubitemid 44026420)
23. P. S. Tofts, " Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 10 (3), 223-232 (1999). 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI23.0.CO;2-S
24. P. S. Tofts, " Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 7 (1), 91-101 (1997). 10.1002/jmri.1880070113 (Pubitemid 28365643)
25. C. S. Patlak, R. G. Blasberg, and J. D. Fenstermacher, " Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.," J. Cereb. Blood Flow Metab. JCBMDN 0271-678X 3 (1), 1-7 (1983).
26. H. Daldrup, " Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media.," AJR, Am. J. Roentgenol. AAJRDX 0361-803X 171 (4), 941-949 (1998). (Pubitemid 28449949)
27. K. Turetschek, " Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 20 (1), 138-144 (2004). 10.1002/jmri.20049 (Pubitemid 38857527)
28. H. L. Cheng, C. Wallis, Z. Shou, and W. A. Farhat, " Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 25 (1), 137-145 (2007). 10.1002/jmri.20787 (Pubitemid 46095208)
29. S. B. Donaldson, " A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: Application in carcinoma of the cervix.," Magn. Reson. Med. MRMEEN 0740-3194 63 (3), 691-700 (2010). 10.1002/mrm.22217
30. D. L. Buckley, " Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI.," Magn. Reson. Med. MRMEEN 0740-3194 47 (3), 601-606 (2002). 10.1002/mrm.10080 (Pubitemid 34194016)
31. I. E. Hoefer, N. van Royen, I. R. Buschmann, J. J. Piek, and W. Schaper, " Time course of arteriogenesis following femoral artery occlusion in the rabbit.," Cardiovasc. Res. CVREAU 0008-6363 49 (3), 609-617 (2001). 10.1016/S0008-6363(00)00243-1 (Pubitemid 32146424)
32. W. Schaper and J. Schaper, Arteriogenesis (Kluwer Academic, Boston, 2004). 10.1007/b111191
33. J. C. Hershey, " Revascularization in the rabbit hindlimb: Dissociation between capillary sprouting and arteriogenesis.," Cardiovasc. Res. CVREAU 0008-6363 49 (3), 618-625 (2001). 10.1016/S0008-6363(00)00232-7 (Pubitemid 32146425)
34. G. Radegran and J. A. Calbet, " Role of adenosine in exercise-induced human skeletal muscle vasodilatation.," Acta Physiol. Scand. APSCAX 0001-6772 171 (2), 177-185 (2001). 10.1046/j.1365-201x.2001.00796. x
35. E. K. Fram, " Rapid calculation of T1 using variable flip angle gradient refocused imaging.," Magn. Reson. Imaging MRIMDQ 0730-725X 5 (3), 201-208 (1987). 10.1016/0730-725X(87)90021-X (Pubitemid 17133355)
36. E. M. Haacke, R. W. Brown, M. R. Thompson, and R. Venkatesan, Magnetic Resonance Imaging: Physical Principles and Sequence Design (Wiley, New York, 1999).
37. M. Rohrer, H. Bauer, J. Mintorovitch, M. Requardt, and H. J. Weinmann, " Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.," Invest. Radiol. INVRAV 0020-9996 40 (11), 715-724 (2005). 10.1097/01.rli.0000184756.66360.d3 (Pubitemid 41546838)
38. J. R. Ewing, " Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor.," J. Cereb. Blood Flow Metab. JCBMDN 0271-678X 26 (3), 310-320 (2006). 10.1038/sj.jcbfm.9600189
39. D. Bates and D. Watts, Nonlinear Regression Analysis and Its Applications (Wiley, New York, 1988).
40. F. Bourasset, A. Dencausse, P. Bourrinet, M. Ducret, and C. Corot, " Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model.," MAGMA (N.Y.) MAGMEY 0968-5243 12 (2-3), 82-87 (2001). 10.1007/BF02668086
41. J. L. Evelhoch, " Key factors in the acquisition of contrast kinetic data for oncology.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 10 (3), 254-259 (1999). 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI53.0.CO;2-9
42. H. E. Daldrup-Link, " Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging.," Acad. Radiol. ZZZZZZ 1076-6332 7 (11), 934-944 (2000). 10.1016/S1076-6332(00)80175-0
43. M. Y. Su, Z. Wang, P. M. Carpenter, X. Lao, A. Muhler, and O. Nalcioglu, " Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 9 (2), 177-186 (1999). 10.1002/(SICI)1522-2586(199902) 9:2<177::AID-JMRI53.0.CO;2-8
44. L. E. Gerlowski and R. K. Jain, " Microvascular permeability of normal and neoplastic tissues.," Microvasc. Res. MIVRA6 0026-2862 31 (3), 288-305 (1986). 10.1016/0026-2862(86)90018-X (Pubitemid 16076428)
45. L. C. Wang and D. Kernell, " Fibre type regionalisation in lower hindlimb muscles of rabbit, rat and mouse: A comparative study.," J. Anat. JOANAY 0021-8782 199, 631-643 (2001). 10.1046/j.1469-7580.2001.19960631.x (Pubitemid 34023813)
46. L. Ludemann, B. Schmitt, P. Podrabsky, B. Schnackenburg, J. Bock, and M. Gutberlet, " Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.," Eur. J. Radiol. EJRADR 0720-048X 62 (2), 247-256 (2007). 10.1016/j.ejrad.2006.12.002 (Pubitemid 46560341)
47. K. Turetschek, " Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology.," Magn. Reson. Med. MRMEEN 0740-3194 45 (5), 880-886 (2001). 10.1002/mrm.1117 (Pubitemid 32402031)
48. A. Jacquier, " MR imaging assessment of the kinetics of P846, a new gadolinium-based MR contrast medium, in ischemically injured myocardium.," Contrast Media Mol. Imaging 3 (3), 112-119 (2008). 10.1002/cmmi.237 1555-4309
49. R. B. Lauffer, " MS-325: Albumin-targeted contrast agent for MR angiography.," Radiology RADLAX 0033-8419 207 (2), 529-538 (1998).
50. C. Corot, X. Violas, P. Robert, G. Gagneur, and M. Port, " Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.," Invest. Radiol. INVRAV 0020-9996 38 (6), 311-319 (2003). 10.1097/00004424-200306000-00002 (Pubitemid 36627248)
51. K. Turetschek, " MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology.," J. Magn. Reson Imaging ZZZZZZ 1053-1807 14 (3), 237-242 (2001). 10.1002/jmri.1179 (Pubitemid 32801057)
52. B. L. Gerber, " Single-vessel coronary artery stenosis: Myocardial perfusion imaging with Gadomer-17 first-pass MR imaging in a swine model of comparison with gadopentetate dimeglumine.," Radiology RADLAX 0033-8419 225 (1), 104-112 (2002). 10.1148/radiol.2251011377
53. K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd, " Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function.," Circulation CIRCAZ 0009-7322 104 (10), 1101-1107 (2001). 10.1161/hc3501.096798